Overview

• Point72 Private Investments led the Series B, joined by existing backers Blackbird, Headline and Latitude/LocalGlobe, bringing Heidi’s total funding to about $97 million.
• Heidi says the funds will accelerate growth in the US, UK and Canada, include a plan to double UK headcount to meet NHS demand, and support a regional office build‑out in Hong Kong or Singapore.
• The company’s AI care partner automates clinical documentation, evidence search, coding and follow‑ups, and a newly announced agent can place calls to patients on a clinician’s behalf.
• Company‑reported adoption includes use by more than 60% of NHS GPs supporting roughly 340,000 weekly consultations in the UK, plus 73 million consults over 18 months and more than 18 million clinician hours returned globally.
• Deployments and pilots span Modality Partnership and Cambridge University Hospitals in the UK, Beth Israel Lahey Health and MaineGeneral in the US, Yukon Government in Canada, and Monash Health and Queensland Children’s Hospital in Australia, with New Zealand’s health ministry endorsing trials.